Alberto J. Espay, MD, MSc, discusses a new biological definition of Parkinson's disease that is based on pathology identified through spinal fluid testing. The test uses the principles of ...
A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...
To the clinical eye, Parkinson’s Disease is defined by the degradation of dopamine-producing neurons in the substantia nigra. But to the patient, the definition is far more visceral: it is the ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression. According to ...
December 1, 2010 — A 28-member expert panel of the American Academy of Neurology (AAN) has developed and published a set of 10 quality measures for the care of patients with Parkinson's disease (PD).